Ilham Kadri - Solvay SA Chairman of the Management Board, CEO, Director
| SVYSF Stock | USD 35.25 2.00 6.02% |
Chairman
Dr. Ilham Kadri was appointed Chairwoman of the Executive Committee, Chief Executive Officer and Director of Solvay SA as of March 1, 2019. Currently, sheis CEO and President of U.S. hygiene technology and services company Diversey and has led, since 2013, its turnaround, carveout and divestment to a private equity fund. She has international experience having worked for top multinationals like ShellBasell, UCBCytec, Huntsman and Dow Chemical across the United States, Europe, the Middle East and in Asia. since 2019.
| Age | 54 |
| Tenure | 5 years |
| Professional Marks | Ph.D |
| Phone | 32 2 264 21 11 |
| Web | https://www.solvay.com |
Solvay SA Management Efficiency
The company has return on total asset (ROA) of 0.0627 % which means that it generated a profit of $0.0627 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.191 %, meaning that it generated $0.191 on every $100 dollars invested by stockholders. Solvay SA's management efficiency ratios could be used to measure how well Solvay SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | CHAIRMAN Age | ||
| Ilan Kaufthal | Tronox Holdings PLC | 73 | |
| Lori Ryerkerk | Celanese | 58 | |
| Lori BS | Celanese | 61 | |
| Joao Cox | Braskem SA Class | 57 | |
| James Fitterling | Dow Inc | 62 | |
| Cynthia Egan | Huntsman | 66 | |
| Nolan Archibald | Huntsman | 76 | |
| Jeff Fettig | Dow Inc | 64 | |
| James Chao | Westlake Chemical Partners | 72 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0627 |
Solvay SA Leadership Team
Elected by the shareholders, the Solvay SA's board of directors comprises two types of representatives: Solvay SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Solvay. The board's role is to monitor Solvay SA's management team and ensure that shareholders' interests are well served. Solvay SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Solvay SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nathalie Ypersele, Head Communication | ||
| Marc Chollet, Chief Committee | ||
| Dominikus Golsong, Group Committee | ||
| Geoffroy Raskin, Head Relations | ||
| Ilham Kadri, Chairman of the Management Board, CEO, Director | ||
| Herve Tiberghien, Chief Committee | ||
| Jodi Allen, Head Relations | ||
| Augusto Donfrancesco, Pres Committee | ||
| Karim Hajjar, CFO Committee | ||
| An Nuyttens, Pres Buses |
Solvay Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Solvay SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.0627 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 12.52 B | |||
| Shares Outstanding | 103.64 M | |||
| Shares Owned By Insiders | 30.70 % | |||
| Shares Owned By Institutions | 20.91 % | |||
| Price To Earning | 5.27 X | |||
| Price To Book | 0.85 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Solvay Pink Sheet
Solvay SA financial ratios help investors to determine whether Solvay Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Solvay with respect to the benefits of owning Solvay SA security.